MedTrace Logo

Use of Melatonin for Preventing POCD in Transurethral Prostate Resection Under Spinal Anesthesia

NCT03966950 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2019-05-29

No results posted yet for this study

Summary

This study aims to evaluate the possible effect of melatonin on prevention of cognitive dysfunction in the postoperative period of elderly patients undergoing transurethral resection of the prostate (TURP) under spinal anesthesia

Conditions

  • Melatonin
  • Cognitive Dysfunction
  • Postoperative Complications
  • Prostate Hyperplasia

Interventions

DIETARY_SUPPLEMENT

melatonin

melatonin 10 mg per os in the preoperative night and the immediate postoperative night and the first and second postoperative nights.

DRUG

Placebo oral tablet

placebo taken per os in the preoperative night and the immediate postoperative night and the first and second postoperative nights

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Maria JC Carmona, PHD · Associate Professor

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-26
Primary Completion
2019-11-26
Completion
2021-11-26

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03966950 on ClinicalTrials.gov